The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

22 Sep 2008 07:00

RNS Number : 9066D
HydroDec Group plc
22 September 2008
 



22nd September 2008

Hydrodec Group plc

Unaudited Interim Results

Hydrodec Group plc (AIM: HYR) today announces unaudited Interim Results for the six months ended 30 June 2008.

Operational:

First US plant in Ohio completed on time and under budget

Acquisition of Virotec International plc

CSIRO royalty pre-paid

Commencement of export sales of SUPERfineTM to Turkey from Australia

Development of Japanese market commenced

Successful £5.0m placing in April 2008

Commitment for off-take of over 50% of Ohio production

Construction go-ahead for the second US plant in LaurelMississippi 

Financial:

Revenues: £2,039,312 (2007: £689,666

Net operating loss £1,285,697 (2007: £1,167,153)

Net assets £27,243,271 (2007: £12,391,962)

Hydrodec Chairman John Gunn commented: "It was a great achievement to complete the CantonOhio plant on schedule and ahead of budgetThe response to SUPERfineTM in the US has been very positive, reflected by the securing of off-take demand in excess of 50% of Canton's capacity before production has started. This is a significant testament to the market's reaction to the quality of SUPERfineTM oil and the viability of Hydrodec's business model. 

The Board has approved commencement of the LaurelMississippi plant and commissioning is expected in 2009 with further pre-sales already taken. Australia's plant in Young, New South Wales, has continued smooth operation.

Our entry into the Japanese market is also making great progress. The recent signing of a MOU with Kobelco Eco-Solutions Co., Ltd. (KES), in Japan sets the Company up to meet our objective to commence construction of a facility in Japan during 2009. The acquisition of Virotec and the CSIRO royalty streams has eliminated a 10% charge on gross future revenue. This additional profit can be re-invested into the business to fund future growth and business opportunities.

  As demand and recognition for SUPERfineTM grows in the US and the worldwide increase in demand for transformer oil continues, Hydrodec is now well positioned to provide a sustainable resource for its customers."

For further information please contact: 

Hydrodec Group plc 020 7621 5774

John Gunn, Chairman

Numis Securities Limited 020 7260 1000

Nominated Adviser: Simon Blank

Corporate Broker: David Poutney/ Alex Ham

Curve PR 07764 197003

Emma Davis

  

CHAIRMAN'S STATEMENT 

I am pleased to present Hydrodec's unaudited interim accounts for the six months ended 30 June 2008. Hydrodec's technology is an oil refining process, producing new speciality oils, using spent oil as the primary feedstock. The process also removes dangerous contaminants such as PCB's from oil and similar fluids. The technology can be applied to many speciality oils, but initially the Company is concentrating on the transformer oil industry. Old transformer oil that has been refined through the Hydrodec process becomes SUPERfineTM oil.

Results for six months ended 30 June 2008

Turnover for the period increased by 196% over the first half of 2007 to £2,039,312 (2007: £689,666), with an overall operating loss of £1,285,697 (2007: £1,167,153). The operating loss includes £507,240 of depreciation and the amortisation. Net assets increased by 120% to £27,243,271 (30 June 2007: £12,391,962), including cash balances of £8,991,049 (30 June 2007: £2,284,324).

Commercial developments 

USA

The handover from construction to commissioning for the new CantonOhio refinery took place in the week commencing 16th June. During that week, the plant was pressurised and final dry testing commenced ahead of catalyst conditioning and first oil feed to the reactors. Since then, SUPERfineTM transformer oil has completed wet commissioning and then independent quality assurance verification. Samples of the oil have now been sent to Hydrodec's customers for their final approval. Canton has a production capacity in excess of 80,000 litres per day.

There is already a commitment for the purchase of greater than 50% of the maximum production capacity of the new Canton plant plus a firm expression of interest in increasing purchase quantities upon commissioning of the LaurelMississippi plant.

Construction of the second US plant in Laurel continues. With a similar capital investment, this plant will be 1 ½ times the size of Canton and will have a production capacity of 120,000 litres per day. It is scheduled to start commercial operations during the second half of 2009. Once operating, these plants will represent a ten fold increase of Hydrodec's existing SUPERfineTM production capacity.

Japan

Visits to the Australian plant by key Japanese parties commenced in March 2008 and in June Hydrodec announced the signing of a MOU with Sanyu Plant Service Co (Sanyu). Commencement of work on this MOU has lead to the development of a more powerful MOU with KES, a majority owned subsidiary of Kobe Steel, and one of Japans most respected industrial companies. Sanyu has withdrawn on amicable terms in favour of KES. 

KES is the environmental business unit of the Kobe Steel Group, one of Japan's most prominent industrial companies. KES has extensive business in the treatment of PCB contaminated electrical equipment and transformer oil, has advanced technology and engineering capabilities in the environmental field, has strong research and development capabilities and has established and comprehensive links with the Japanese power industry.

The MOU with KES creates a binding agreement between the companies and commits Hydrodec exclusively to KES for the six month term of the agreement. The objectives of the agreement include finalisation of the feasibility of the Hydrodec business in Japan, establishment of terms under which the parties may enter into a cooperative business arrangement in Japan and documentation of the terms of conduct of a mutually acceptable master agreement between the parties.

Australia

In May and June SUPERfineTM sales averaged 500,000 litres per month, close to the maximum capacity of the plant. The Young plant continues to supply Turkey and to meet continued growing demand from the domestic market. 

Placing

Hydrodec placed 10,000,000 new ordinary shares at a price of 50.0 pence per share to raise £5.0 million (before expenses) in April. The placing provided Hydrodec with additional funds required for its offer for Virotec International plc as well as for general corporate purposes, including the further expansion of Hydrodec's operations.

Acquisitions

The acquisition of Virotec International plc ("VTI") was completed in June for a total consideration of £35.2 million, a breakdown of which is contained at Note 8 in the releaseThis resulted in an additional 64,689,227 new Hydrodec shares being issued. The assets acquired included the royalty stream owed to Virotec as well as Virotec's 54.5 million Hydrodec shares.  These are now held as treasury shares.

The other royalty stream Hydrodec paid was due to CSIRO (Commonwealth Scientific and Industrial Research Organisation), owner and licensor of the Hydrodec patent. This was a royalty of 5% of the gross revenue earned by the company from the Hydrodec technology for the life of the patent. In May, CSIRO agreed to accept a one-off cash payment of AUD$5.6 million (£2.7 million) as complete pre-payment of all royalties due under the Hydrodec technology licence agreement (the "Licence Agreement"). 

The transformer oil market

Continued price volatility in crude oil markets has seen a corresponding volatility in the price of used oil as well as transformer oil. Furthermore unusually violent storms in the Gulf Coast area have impacted production and refinery capacity in Texas and Louisiana that has had a direct impact on base oil supplies. Based upon these and other factors, the market price for transformer oil increased during the period. List price increases were announced by producers in the USA and escalating crude oil prices have started to feed through to the market place. Power industry infrastructure replacement programs and upgrades are also gathering momentum in the USA and Australia, increasing short and medium term demand for transformer oils. The ongoing tight supply situation combined with increasing price and demand is providing progressive improvement in Hydrodec's competitive position in its two current key markets Australia and the USA and its potential Japanese market. In addition a major opportunity exists for the treatment of PCB contaminated oil especially in JapanUSA and Europe.

Current trading

SUPERfineTM sales volumes have increased throughout the period and this trend has continued post period end.

The future

Sales progress in Australia continues to be encouraging with repeat orders from Turkey and an increased level of interest from the domestic market. Opportunities exist for the Australian plant to supply other countries such as IndonesiaNew Zealand, and possibly the West Coast of the USA and these are actively being pursued. 

The treatment of other specialty oils for recycling e.g. hydraulic oils continues to be evaluated at the request of major producers and users in this sector and it is hoped this will lead to significant commercial opportunities. The market potential for Hydrodec in these areas is many times the size of the transformer oil market. In addition, Hydrodec has ambitions to establish a re-manufacturing business for dangerous waste products such as PCBs and POPs.

The potential for Hydrodec in the USAJapan and other international markets is huge and exciting opportunities await us. We are confident in the quality of SUPERfineTM and believe that we can satisfy customer demand and exceed customer expectations. The commencement of the Canton plant in September marks a milestone for Hydrodec as it becomes a global company.

The dynamics of the global transformer oil market continue to move in favour of SUPERfineTM oil. The key advantages of sustainability, a predictable price and supply and the world-class product that Hydrodec provide remain as compelling as ever in today's market place. I look forward to announcing further significant corporate and commercial developments soon.

John Gunn

Non-executive Chairman

22nd September 2008

  CONSOLIDATED PROFIT AND LOSS

Note

(Unaudited)

6 months ended 30 June 2008 

(Unaudited)

6 months ended 30 June 2007 

£

£

Turnover

2,039,312

689,666

Cost of sales

(496,385)

(271,180)

Gross profit

1,542,927

418,486

Administrative expenses

(2,828,624)

(1,585,639)

Operating loss

(1,285,697)

(1,167,153)

Interest income/(expenditure)

6

(573,763)

21,149

Loss on ordinary activities before and after taxation

(1,859,460)

(1,146,004)

Loss retained for the period

(1,859,460)

(1,146,004)

Loss per share

Basic

(0.96)p

(0.62)p

STATEMENT OF TOTAL RECOGNISED GAINS AND LOSSES

(Unaudited)

6 months

 ended 

30 June 2008 

(Unaudited)

6 months

 ended 

30 June 2007 

£

£

Loss for the financial period

(1,859,460)

(1,146,004)

Currency differences

343,380

181,312

Total recognised losses

(1,516,080)

(964,692)

  CONSOLIDATED BALANCE SHEET

Note

(Unaudited)

As at

30 June 2008 

(Unaudited)

As at

30 June 2007 

£

£

Non-current assets

Tangible assets

9,786,252

3,843,678

Intangible

7

15,032,453

6,555,003

Other non-current assets - prepaid royalties

2,704,240

-

27,522,945

10,398,681

Current assets

Debtors

854,336

323,863

Investment

8

2,227,500

-

Inventory

105,978

189,022

Prepayments and other receivables

652,954

68,170

Cash at bank and in hand

8,991,049

2,284,324

12,831,817

2,865,379

Current trade and other creditors

(6,603,323)

(445,070)

Net current assets

6,228,494

2,420,309

Non current liabilities

(6,508,168)

(427,028)

Total assets less liabilities

27,243,271

12,391,962

Capital and reserves

Called up share capital

1,332,727

969,227

Share premium account

53,570,935

19,125,567

Equity reserve

9,538,900

-

EBT and treasury shares

(27,440,095)

-

Share options reserve

2,690,389

2,253,134

Foreign exchange reserve

496,996

(3,704)

Profit and loss account

(12,946,581)

(9,952,262)

Equity shareholders' funds

9

27,243,271

12,391,962

  CASH FLOW STATEMENT

Note

(Unaudited)

6 months

 ended 

30 June 2008

 

(Unaudited)

6 months

 ended 

30 June 2007

 

£

£

Cashflows from operating activities

Operating loss

(1,285,697)

(1,167,153)

Depreciation

245,040

95,899

Amortisation of other intangible assets

262,200

262,200

Finance costs

-

138,686

Share based payment expense

213,000

113,082

Foreign exchange movement

343,380

(3,749)

Increase in inventories

26,833

(113,661)

(Increase)/decrease in amounts receivable

736,155

(207,421)

Increase/(decrease) in amounts payable

(1,148,838)

(23,676)

Net cash outflow from operating activities

(607,927)

(905,793)

Cashflows from investing activities

Purchase of property plant and equipment

(3,172,833)

(134,173)

Purchase of Investment

(4,111,677)

-

Interest paid

(165,600)

-

Bank interest and other income received

200,213

21,149

Net cash outflow from investing activities

(7,249,897)

(113,024)

Cashflows from financing activities

Issue of new shares

5,000,000

2,300,000

Costs of share issue

(200,000)

(19,729)

Repayment of lease liabilities

(80,311)

-

Net cash inflow from financing

4,719,689

2,280,271

Increase/(decrease) in cash and cash equivalents

(3,138,135)

1,261,444

Movement in net cash

Opening cash and cash equivalents

12,129,184

891,913

Increase/(decrease) in cash and cash equivalents

(3,138,135)

1,261,444

Closing cash and cash equivalents

8,991,049

2,153,357

  NOTES TO THE INTERIM REPORT

 

1 BASIS OF PREPARATION   

The interim consolidated financial statements for the six months ended 30 June 2008 have been prepared under applicable International Financial Reporting Standards adopted by the European Union ("IFRS") which include International Accounting Standards and interpretations issued by the International Accounting Standards Board and its committees, which are expected to be endorsed by the European Union.

This interim financial information has been prepared on the historical cost basis. The accounting policies applied are consistent with those adopted and disclosed in the annual financial statements for the period ended 31 December 2007

The financial information is unaudited and has not been reviewed by the auditor.

2 publication of non-statutory accounts

The financial information set out in this interim report does not constitute statutory accounts as defined in Section 240 of the Companies Act 1985.

3 TAXATION

There is no tax charge for the interim period.

4 EARNINGS PER SHARE

6 months ended

30 June 2008

6 months ended

30 June 2007

£

£

Loss for the financial period

(1,859,460)

(1,146,005)

Number

 of shares

Number

 of shares

Weighted average number of shares in issue*

193,857,392

185,611,148

* The weighted average shares on issue have been reduced by the weighted average number of Treasury and EBT shares held. 

For basic earnings per share

( 0.96 )p

(0.62)p

5 DIVIDENDS

No dividends have been paid or proposed for the period.

  

6 INTEREST

6 months ended

30 June 2008

6 months ended

30 June 2007

£

£

Interest expense - Convertible Notes

(786,007)

-

Interest income

212,244

21,149

Net Interest for the financial period

(573,763)

21,149

7 INTANGIBLE ASSETS

Note

(Unaudited)

£

Cost

At 31 December 2007

9,868,780

Intangible assets acquired 

8

9,001,850

At 30 June 2008

18,870,630

Amortisation

At 31 December 2007

3,575,977

Charge for the period

262,200

At 30 June 2008

3,838,177

Net book value 

At 30 June 2008

15,032,453

At 31 December 2007

6,292,803

  8 Acquisition of virotec international plc

The acquisition of the Virotec International plc Group ("VTI") was completed on 25 June 2008. The acquisition was a cash and scrip offer and was funded from existing cash reserves. The offer was completed by the issue of 64,689,227 ordinary shares and the payment of £2.8 million. 

The acquisition of VTI had the following effect on the Group's assets and liabilities:

Book value

Fair value adjustments

Provisional fair values

£

£

£

Intangible assets**

-

6,924,500

6,924,500

Property, plant and equipment

-

-

-

Treasury stock*

-

26,160,000

26,160,000

Investments***

5,180,141

(2,952,641)

2,227,500

Trade receivables and other debtors

82,335

-

82,335

Cash at bank

7,979

-

7,979

Current liabilities

(212,435)

-

(212,435)

Provisions 

-

-

-

Deferred tax liabilities

-

(2,077,350)

(2,077,350)

5,058,020

28,054,509

33,112,529

Net cash paid****

3,456,428

Shares issued

30,007,629

Deferred consideration

604,951

Acquisition costs

1,120,871

Consideration

35,189,879

Goodwill on acquisition

2,077,350

* The acquisition of VTI included 54.5 million shares in the Hydrodec Group. These shares have been treated as Treasury Stock.

** Intangible asset acquired is the Royalty payable from Hydrodec to VTI.

*** Investment represents shares held in Molectra Group Ltd (previously The Greenhouse Fund Ltd) 

**** Net cash includes £648,750 relating to Virotec shares purchased prior to the offer being made.  

Fair values have been assessed on a provisional basis pending finalisation of the rationalisation of group accounting procedures, which cover a number of different reporting regimes throughout the world. Deferred tax has been provided on all fair value adjustments as applicable and on purchased goodwill where a tax benefit will be obtained against future taxable benefits.

The valuation of intangible assets has been estimated at this stage.

  9 RECONCILIATION OF MOVeMENT IN SHAREHOLDERS' FUNDS

(Unaudited)

As at

30 June 2008

No.

Authorised

Ordinary shares of 0.5 pence each

800,000,000

Issued and fully paid - ordinary shares of 0.5 pence each

At 31 December 2007

193,845,400

Issues to acquire investment

64,689,227

Issued to satisfy Convertible Notes

184,212

Issued for cash

10,000,000

At 30 June 2008

268,718,839

The company issued the following 0.5 pence ordinary shares during the period:

Date of issue

Number of shares

Issue price

Total consideration

£

21 April 2008

10,000,000

50 pence

5,000,000

27 May 2008

184,212

19 pence

35,000

25 June 2008

64,689,227

48 pence

31,050,829*

Net share consideration for Acquisition of Virotec International plc (VTI)

Total share consideration

31,050,829

Less shares issued to Hydrodec as a VTI shareholder 

(1,043,200)

Net Consideration in Note 8

30,007,626

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SFUFIUSASELU
Date   Source Headline
6th Apr 20217:00 amRNSCancellation - Hydrodec Group plc
1st Apr 20215:30 pmRNSHydrodec Group
31st Mar 20217:00 amRNSBusiness Update
3rd Feb 20213:42 pmRNSFinancing update
2nd Oct 20201:26 pmRNSHolding(s) in Company
1st Oct 20207:30 amRNSSuspension - Hydrodec Group plc
1st Oct 20207:00 amRNSTrading and year end update
13th Jul 20203:06 pmRNSHolding(s) in Company
10th Jul 20209:05 amRNSHolding(s) in Company
26th Jun 20207:00 amRNSAnnual Report and Accounts Extension
19th May 20207:00 amRNSTrading Update
7th Apr 20207:00 amRNSHolding(s) in Company
24th Mar 20201:08 pmRNSCanton facility update
14th Feb 20207:00 amRNSTrading Update
2nd Jan 20204:47 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSFinancing update
6th Dec 20197:30 amRNSDirectorate Change
21st Nov 20197:00 amRNSHolding(s) in Company
6th Nov 20199:14 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSHolding(s) in Company
2nd Oct 201911:01 amRNSHolding(s) in Company
30th Sep 20194:40 pmRNSSecond Price Monitoring Extn
30th Sep 20194:35 pmRNSPrice Monitoring Extension
30th Sep 201911:09 amRNSChange of Registered Office
30th Sep 201911:01 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSUnaudited Interim Results
13th Aug 20197:00 amRNSDisposal of Hydrodec's Australian Plant
1st Jul 20191:14 pmRNSUpdate on the sale of Australian operations
20th Jun 20195:49 pmRNSResult of AGM
20th Jun 20197:00 amRNSAGM Statement
28th May 201910:14 amRNS2018 Annual Report and Accounts and Notice of AGM
28th May 20197:00 amRNSFinal Results
2nd Apr 20197:00 amRNSGrant of Options
29th Mar 20197:00 amRNSPre-close Trading Update
12th Mar 20197:00 amRNSBoard Changes and Appointments at HoNA
31st Dec 20181:26 pmRNSHolding(s) in Company
28th Dec 20187:00 amRNSHydrodec takes control of N.American operations
1st Nov 20183:50 pmRNSChange of Registered Office
1st Nov 20181:00 pmRNSHolding(s) in Company
31st Oct 20183:10 pmRNSHolding(s) in Company
31st Oct 20189:20 amRNSHolding(s) in Company
30th Oct 20185:15 pmRNSHolding(s) in Company
30th Oct 20184:30 pmRNSHolding(s) in Company
30th Oct 20182:30 pmRNSHolding(s) in Company
30th Oct 20182:30 pmRNSHolding(s) in Company
25th Oct 201811:00 amRNSResult of General Meeting
25th Oct 20187:00 amRNSResult of Open Offer
9th Oct 20183:30 pmRNSPosting of circular and notice of general meeting
8th Oct 201810:20 amRNSResult of Placing
8th Oct 20189:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.